Related Experiment Video
Updated: Mar 3, 2026

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
Immunohistochemical profile of ING3 protein in normal and cancerous tissues
Wen-Feng Gou1, Xue-Feng Yang1, Dao-Fu Shen1
1Cancer Center, The First Affiliated Hospital of Liaoning Medical University, Jinzhou, Liaoning 121001, P.R. China.
Abstract:
The inhibitor of growth family, member 3 (ING3) protein may be capable of blocking the cell cycle via activating p53-transactivated promoters of p21 and Bcl2-associated X protein, and may induce apoptosis via a Fas/caspase-8-dependent signaling pathway. In the present study, immunohistochemistry was performed in order to characterize the expression profile of ING3 protein in tissue microarrays containing mouse and human normal tissue, human hepatocellular (n=62), renal clear cell (n=62), pancreatic (n=62), esophageal squamous cell (n=45), cervical squamous cell (n=31), breast (n=144), gastric (n=196), colorectal (n=96), ovarian (n=208), endometrial (n=96) and lung carcinoma (n=192). In mouse tissue, ING3 protein was positively detected in the cytoplasm of cardiomyocytes, kidney and skeletal muscle cells, and was additionally detected in the cytoplasm and nucleus of bronchial and alveolar epithelium, gastric and intestinal gland, and mammary gland cells. In human tissues, ING3 protein was principally distributed in the cytoplasm, but was observed in the cytoplasm and nucleus of tongue, esophagus, stomach, intestine, lung, skin, appendix, bladder, cervix and breast cells. ING3 immunoreactivity was strongly detected in the stomach, skin and cervical tissues, whereas a weak signal was detected in the cerebellum, brain stem, thymus, liver, skeletal muscle, testis and prostate. In total, ING3-positive specimens were identified in 424 of 1,194 tested cancer entities (35.5%). In a number of cases, ING3 expression was observed to be restricted to the cytoplasm and nucleus, excluding the cytoplasmic distribution identified in breast and hepatocellular carcinoma. Among these cases, ING3 was more frequently expressed in breast and gynecological types of cancer, including ovarian (59.2%), endometrial (47.9%), breast (38.9%) and cervical (35.5%) cancer. ING3-positive cases were more rare in renal clear cell (17.7%), hepatocellular (16.1%) and esophageal carcinoma (17.8%). It is suggested that ING3 may be involved in the repair and regeneration of organs or tissues, and may be closely associated with gynecological carcinogenesis.
Insights
The inhibitor of growth family, member 3 (ING3) protein is expressed in various human tissues and cancers. ING3 shows higher expression in breast and gynecological cancers, suggesting a role in carcinogenesis.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- The inhibitor of growth family, member 3 (ING3) protein is implicated in cell cycle regulation and apoptosis.
- ING3's precise expression patterns in normal and cancerous human tissues are not fully elucidated.
Purpose of the Study:
- To characterize the expression profile of ING3 protein in a wide range of normal human and mouse tissues.
- To investigate the expression of ING3 in various human carcinoma types, including breast, gynecological, and others.
- To explore the potential association of ING3 expression with specific cancer types and carcinogenesis.
Main Methods:
- Immunohistochemistry was employed to detect ING3 protein expression.
- Tissue microarrays containing normal mouse and human tissues were analyzed.
- Expression levels of ING3 were assessed in 1,194 human cancer specimens across multiple carcinoma types.
Main Results:
- ING3 protein was detected in various normal mouse tissues (cardiomyocytes, kidney, skeletal muscle, bronchial/alveolar epithelium, gastric/intestinal glands, mammary glands).
- In human tissues, ING3 was primarily cytoplasmic but also nuclear in tongue, esophagus, stomach, intestine, lung, skin, appendix, bladder, cervix, and breast.
- ING3 was detected in 35.5% of tested cancers, with higher prevalence in ovarian (59.2%), endometrial (47.9%), breast (38.9%), and cervical (35.5%) cancers.
- Lower ING3 expression was observed in renal clear cell (17.7%), hepatocellular (16.1%), and esophageal (17.8%) carcinomas.
Conclusions:
- ING3 protein exhibits distinct expression patterns in normal human and mouse tissues.
- ING3 expression is significantly associated with breast and gynecological cancers.
- ING3 may play a role in tissue repair, regeneration, and gynecological carcinogenesis.

